Home » Stocks » CJJD

China Jo-Jo Drugstores, Inc. (CJJD)

Stock Price: $1.20 USD 0.01 (0.84%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $1.17 -0.03 (-2.50%) Jan 22, 7:01 PM
Market Cap 44.80M
Revenue (ttm) 125.59M
Net Income (ttm) -4.18M
Shares Out 37.96M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $1.20
Previous Close $1.19
Change ($) 0.01
Change (%) 0.84%
Day's Open 1.21
Day's Range 1.17 - 1.27
Day's Volume 1,298,247
52-Week Range 0.90 - 3.35

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 4 months ago

HANGZHOU, China, Sept. 8, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc.

PRNewsWire - 5 months ago

HANGZHOU, China, Aug. 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc.

PRNewsWire - 6 months ago

HANGZHOU, China, July 10, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor o...

PRNewsWire - 7 months ago

HANGZHOU, China, June 1, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of...

About CJJD

China Jo-Jo Drugstores, together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such... [Read more...]

Industry
Pharmaceutical Retailers
Founded
2003
CEO
Lei Liu
Employees
1,014
Stock Exchange
NASDAQ
Ticker Symbol
CJJD
Full Company Profile

Financial Performance

In 2019, CJJD's revenue was $117.33 million, an increase of 9.09% compared to the previous year's $107.55 million. Losses were -$5.81 million, 527.6% more than in 2018.

Financial Statements